---
title: "BEST-CLI: One year on"
date: "2024-01-12T13:58:40.000Z"
publishedDate: "12 janvier 2024"
summary: "A dedicated session at the 2023 VEITHsymposium (14–18 November, New York, USA) aimed to unpack the ways in which clinical practice and attitudes in the field of chronic limb-threatening ischaemia (CLTI) have changed since the BEST-CLI trial was published back in November 2022. The trial’s principal investigators (PIs)—vascular surgeons Alik Farber and Matthew Menard and [&#8230;] The post BEST-CLI: One year on appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/best-cli-one-year-on/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-01-12-best-cli-one-year-on"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2020/11/stats-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/best-cli-one-year-on/"
---

![BEST-CLI: One year on](https://vascularnews.com/wp-content/uploads/sites/7/2020/11/stats-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/best-cli-one-year-on/*

## L’essentiel

A dedicated session at the 2023 VEITHsymposium (14–18 November, New York, USA) aimed to unpack the ways in which clinical practice and attitudes in the field of chronic limb-threatening ischaemia (CLTI) have changed since the BEST-CLI trial was published back in November 2022. The trial’s principal investigators (PIs)—vascular surgeons Alik Farber and Matthew Menard and [&#8230;] The post BEST-CLI: One year on appeared first on Vascular News .

## Lien source

https://vascularnews.com/best-cli-one-year-on/
